GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » 14-Day RSI

Elixinol Wellness (ASX:EXL) 14-Day RSI : 40.59 (As of May. 11, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-11), Elixinol Wellness's 14-Day RSI is 40.59.

The industry rank for Elixinol Wellness's 14-Day RSI or its related term are showing as below:

ASX:EXL's 14-Day RSI is ranked better than
81.61% of 1142 companies
in the Drug Manufacturers industry
Industry Median: 50.595 vs ASX:EXL: 40.59

Competitive Comparison of Elixinol Wellness's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixinol Wellness's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's 14-Day RSI falls into.



Elixinol Wellness  (ASX:EXL) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness  (ASX:EXL) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Elixinol Wellness 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness (ASX:EXL) Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines